Literature DB >> 20865794

Maternal thyroid function at 11 to 13 weeks of gestation and subsequent development of preeclampsia.

Ghalia Ashoor1, Nerea Maiz, Micheal Rotas, Nikos A Kametas, Kypros H Nicolaides.   

Abstract

OBJECTIVE: To determine if maternal thyroid function in the first trimester is altered in pregnancies that subsequently develop preeclampsia (PE).
METHODS: Mean arterial pressure (MAP), uterine artery pulsatility index (PI) maternal serum thyroid stimulating hormone (TSH), free thyroxine (FT4) and free triiodothyronine (FT3) at 11 to 13 weeks of gestation were measured in 102 singleton pregnancies that subsequently developed PE, and the values were compared to the results of 4318 normal pregnancies.
RESULTS: In both the PE groups that required delivery before 34 weeks (early-PE) and the late-PE group, compared with the unaffected group, the median MAP multiple of the normal median (MoM) and uterine artery PI MoM were significantly increased. In late-PE but not in early-PE, compared with the unaffected group, the median TSH MoM was significantly increased and the median FT4 MoM was decreased. Logistic regression analysis demonstrated that TSH MoM provided a significant contribution in the prediction of late-PE.
CONCLUSION: Impaired thyroid function may predispose to the development of late-PE, and measurement of maternal serum TSH can improve the prediction of late-PE provided by a combination of factors in the maternal history and the measurements of MAP and uterine artery PI.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20865794     DOI: 10.1002/pd.2566

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  8 in total

Review 1.  Thyroid disease in pregnancy: new insights in diagnosis and clinical management.

Authors:  Tim I M Korevaar; Marco Medici; Theo J Visser; Robin P Peeters
Journal:  Nat Rev Endocrinol       Date:  2017-08-04       Impact factor: 43.330

2.  Preeclampsia, gestational hypertension and subsequent hypothyroidism.

Authors:  Tuija Männistö; S Ananth Karumanchi; Anneli Pouta; Marja Vääräsmäki; Pauline Mendola; Satu Miettola; Heljä-Marja Surcel; Aini Bloigu; Aimo Ruokonen; Marjo-Riitta Järvelin; Anna-Liisa Hartikainen; Eila Suvanto
Journal:  Pregnancy Hypertens       Date:  2012-09-21       Impact factor: 2.899

3.  Thyroid diseases and adverse pregnancy outcomes in a contemporary US cohort.

Authors:  Tuija Männistö; Pauline Mendola; Jagteshwar Grewal; Yunlong Xie; Zhen Chen; S Katherine Laughon
Journal:  J Clin Endocrinol Metab       Date:  2013-06-06       Impact factor: 5.958

4.  Craniosynostosis and risk factors related to thyroid dysfunction.

Authors:  S L Carmichael; C Ma; S A Rasmussen; M L Cunningham; M L Browne; C Dosiou; E J Lammer; G M Shaw
Journal:  Am J Med Genet A       Date:  2015-02-05       Impact factor: 2.802

5.  Thyroid Function/Antibodies in Sudanese Patients with Preeclampsia.

Authors:  Enaam T Elhaj; Ishag Adam; Ammar Alim; Elhassan M Elhassan; Mohamed F Lutfi
Journal:  Front Endocrinol (Lausanne)       Date:  2015-06-11       Impact factor: 5.555

6.  Association between thyroid hormone parameters during early pregnancy and gestational hypertension: a prospective cohort study.

Authors:  Hua Lai; Zheng-Yu Zhan; Huai Liu
Journal:  J Int Med Res       Date:  2020-02       Impact factor: 1.671

7.  Quantitative ELISAs for serum soluble LHCGR and hCG-LHCGR complex: potential diagnostics in first trimester pregnancy screening for stillbirth, Down's syndrome, preterm delivery and preeclampsia.

Authors:  Anne E Chambers; Christopher Griffin; Samantha A Naif; Ian Mills; Walter E Mills; Argyro Syngelaki; Kypros H Nicolaides; Subhasis Banerjee
Journal:  Reprod Biol Endocrinol       Date:  2012-12-17       Impact factor: 5.211

8.  Correlation of thyroid functions with severity and outcome of pregnancy.

Authors:  S Kharb; D Sardana; S Nanda
Journal:  Ann Med Health Sci Res       Date:  2013-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.